AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery-Reference-Cited by-同舟云学术

AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery

Published:2022-01 Issue:1 Volume:8 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Potjewyd Frances M.¹,Annor‐Gyamfi Joel K.¹,Aubé Jeffrey²,Chu Shaoyou³,Conlon Ivie L.²,Frankowski Kevin J.²,Guduru Shiva K. R.²,Hardy Brian P.²,Hopkins Megan D.²,Kinoshita Chizuru⁴⁵,Kireev Dmitri B.²,Mason Emily R.³,Moerk Charles T.⁴⁵,Nwogbo Felix²,Pearce Kenneth H.²,Richardson Timothy I.³,Rogers David A.²,Soni Disha M.³,Stashko Michael²,Wang Xiaodong²,Wells Carrow¹,Willson Timothy M.¹,Frye Stephen V.²,Young Jessica E.⁴⁵,Axtman Alison D.¹^ORCID

Affiliation:

1. UNC Eshelman School of Pharmacy Division of Chemical Biology and Medicinal Chemistry Structural Genomics Consortium Chapel Hill North Carolina USA

2. UNC Eshelman School of Pharmacy Division of Chemical Biology and Medicinal Chemistry Center for Integrative Chemical Biology and Drug Discovery Chapel Hill North Carolina USA

3. Department of Medicine Division of Clinical Pharmacology Indiana University School of Medicine Indianapolis Indiana USA

4. Department of Laboratory Medicine and Pathology University of Washington Seattle Washington USA

5. Institute for Stem Cell and Regenerative Medicine University of Washington Seattle Washington USA

Funder

National Institutes of Health

Canada Foundation for Innovation

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12246